April 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. (“D-Wave” or “the Company”) (NYSE: QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether D-Wave has violated… read more
April 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FTI Consulting, Inc. (“FTI” or “the Company”) (NYSE: FCN). Investors who purchased FTI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether FTI has violated… read more
April 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of T-Mobile US, Inc. (“T-Mobile” or “the Company”) (NASDAQ: TMUS). Investors who purchased T-Mobile securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether T-Mobile has violated… read more
April 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Landstar System, Inc. (“Landstar” or “the Company”) (NASDAQ: LSTR). Investors who purchased Landstar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Landstar has violated… read more
April 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. (“ICU Medical” or “the Company”) (NASDAQ: ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ICU… read more
April 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Backblaze, Inc. (“Backblaze” or “the Company”) (NASDAQ: BLZE). Investors who purchased Backblaze securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Backblaze has violated federal… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Northrop Grumman Corporation (“Northrop Grumman” or “the Company”) (NYSE: NOC). Investors who purchased Northrop Grumman securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Northrop… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Venture Global, Inc. (“Venture Global” or “the Company”) (NYSE: VG). Investors who purchased Venture Global securities pursuant to the registration statement and prospectus issued in connection with the Company’s January 24,… read more
April 23, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. (“Atkore” or “the Company”) (NYSE: ATKR). Investors who purchased Atkore securities prior to February 17, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
April 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semtech Corporation (“Semtech” or “the Company”) (NASDAQ: SMTC). Investors who purchased Semtech securities prior to August 27, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
April 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gorilla Technology Group Inc. (“Gorilla” or “the Company”) (NASDAQ: GRRR). Investors who purchased Gorilla securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Gorilla has… read more
April 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Uber Technologies, Inc. (“Uber” or “the Company”) (NYSE: UBER). Investors who purchased Uber securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Uber has violated… read more
April 21, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agilysys, Inc. (“Agilysys” or “the Company”) (NASDAQ: AGYS). Investors who purchased Agilysys securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agilysys has violated federal… read more
April 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Movado Group, Inc. (“Movado Group” or “the Company”) (NYSE: MOV). Investors who purchased Movado Group securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Movado… read more
April 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allbirds, Inc. (“Allbirds” or “the Company”) (NASDAQ: BIRD). Investors who purchased Allbirds securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Allbirds has violated federal… read more
April 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Adverum Biotechnologies, Inc. (“Adverum” or “the Company”) (NASDAQ: ADVM). Investors who purchased Adverum securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Adverum has violated… read more
April 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Greenbrier Companies, Inc. (“Greenbrier” or “the Company”) (NYSE: GBX). Investors who purchased Greenbrier securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Greenbrier has… read more
April 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TechTarget, Inc. (“TechTarget” or “the Company”) (NASDAQ: TTGT). Investors who purchased TechTarget securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TechTarget has violated federal… read more
April 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DuPont de Nemours, Inc. (“DuPont” or “the Company”) (NYSE: DD). Investors who purchased DuPont securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether DuPont has… read more
April 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nyxoah S.A. (“Nyxoah” or “the Company”) (NASDAQ: NYXH). Investors who purchased Nyxoah securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Nyxoah has violated federal… read more
April 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Altria Group, Inc. (“Altria” or “the Company”) (NYSE: MO). Investors who purchased Altria securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Altria has violated… read more
March 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Harmony Biosciences Holdings, Inc. (“Harmony” or “the Company”) (NASDAQ: HRMY). Investors who purchased Harmony securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Harmony has… read more
March 24, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Profound Medical Corp. (“Profound” or “the Company”) (NASDAQ: PROF). Investors who purchased Profound securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Profound has violated… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hesai Group (“Hesai” or “the Company”) (NASDAQ: HSAI). Investors who purchased Hesai securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Hesai has violated federal… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of HealthEquity, Inc. (“HealthEquity” or “the Company”) (NASDAQ: HQY). Investors who purchased HealthEquity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether HealthEquity has violated federal… read more
March 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of RLX Technology Inc. (“RLX” or “the Company”) (NYSE: RLX). Investors who purchased RLX securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether RLX has violated… read more
March 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Affirm Holdings, Inc. (“Affirm” or “the Company”) (NASDAQ: AFRM). Investors who purchased Affirm securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Affirm has violated… read more
March 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of XP Inc. (“XP” or “the Company”) (NASDAQ: XP). Investors who purchased XP securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether XP has violated federal… read more
March 18, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of OSI Systems, Inc. (“OSI” or “the Company”) (NASDAQ: OSIS). Investors who purchased OSI securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether OSI has violated… read more
March 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dave Inc. (“Dave” or “the Company”) (NASDAQ: DAVE). Investors who purchased Dave securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Dave has violated federal… read more